Navigation Links
BspT107 I (HgiC I, Ban I) from Takara Mirus Bio

ProductsBspT107 I (HgiC I, Ban I) from Takara Mirus Bio
Company Takara Mirus Bio
Item BspT107 I (HgiC I, Ban I)
Price $252.00
Description 
Info Takara Mirus BioTakara Mirus Bio
510 Charmany Drive
Suite 273
Madison, WI 53719 USA

Call Takara Mirus Bio to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-536-4401
Customer Service: (888) 251-6618 or (608) 441-2844
Fax Number: (608) 441-2845
Web Site: http://www.takaramirusbio.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. GPDH Assay Kit from Takara Mirus Bio
2. Bgl I from Takara Mirus Bio
3. Mun I (Mfe I) from Takara Mirus Bio
4. Acc I from Takara Mirus Bio
5. Sma I (High Concentration) from Takara Mirus Bio
6. Hae III (High Concentration) from Takara Mirus Bio
7. Hae III from Takara Mirus Bio
8. Psp1406 I from Takara Mirus Bio
9. SPACED COVER GLASS S (22X24 MM) from Takara Mirus Bio
10. Kilo Sequencing Deletion Kit from Takara Mirus Bio
11. Cassette, Sal I from Takara Mirus Bio
... for biocompatibility testing at various temperatures, ... air through a clean heating unit ... up to 140F. Transparent panels allow ... allow easy access to the work ...
... Analysis Note: Protein determined by ... 3.2 M (NH 4 ) ... 7.0 Preparation Note: Affinity purified ... suspension • Additives: MgCl 2 ...
... The Label IT siRNA Tracker ... Reagent provides a straight forward approach ... of your design, in an efficient ... tracking experiments. Subcellular localization and functional ...
... PP2A, purified MW: 60kDa (A) ... glycerol, 20mM MOPS, pH 7.5, 500mM ... EGTA, 0.1mM MnCl2 1mM DTT, and ... in vitro dephosphorylation of proteins. Purification: ...
Biology Products:
(Date:12/15/2009)... at VIB and Ghent University in Flanders, Belgium have ... shock, the major cause of death in intensive care ... gas in mice with septic shock, researchers Anje Cauwels ... much less damage, while their chances of survival increased ... generally assumed that nitric oxide is responsible for the ...
(Date:12/15/2009)... Extinct woolly mammoths and ancient American horses may ... several thousand years longer than previously thought. After ... Alaska, a team of researchers used cutting-edge techniques ... in permafrost samples dated to between 7,600 and ... at least one population of these now-extinct mammals ...
(Date:12/15/2009)... ., Despite the fact that physical space ... as to how space is encoded in their language. ... as ,left, right, front, back, to talk about spatial ... west, at all times for all scales: "The spoon ... snake by your Northern leg". Whether not only spatial ...
Breaking Biology News(10 mins):Septic shock: Nitric oxide beneficial after all 2Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4More than a jump to the left 2Gallbladder emptying in primary sclerosing cholangitis patients 54047 1Gallbladder emptying in primary sclerosing cholangitis patients 54047 2STAT3 gene regulates cancer stem cells in brain cancer 9525 1STAT3 gene regulates cancer stem cells in brain cancer 9525 29 11 Responders May Be At Raised Myeloma Risk 54040 19 11 Responders May Be At Raised Myeloma Risk 54040 29 11 Responders May Be At Raised Myeloma Risk 54040 3
... the male-dominated societies of their chimpanzee relatives, bonobo societyin ... a "make-love-not-war" kind of image. While chimpanzee males frequently ... peaceful bonobos were believed to restrict what meat they ... , Not so, according to a study, reported in ...
... of antibodies from a mother to her newborn child ... immune system. Those antibodies, donated by transfer across the ... help shape a baby,s response to foreign pathogens and ... from biologists at the California Institute of Technology (Caltech) ...
... an important hair-loss gene. During their study, the researchers ... found a gene variant which occurs clearly more frequently ... are to be published in the November issue of ... October 12th 2008 18:00 London time, doi: 10.1038/ng.228). In ...
Other Biology News:Despite 'peacenik' reputation, bonobos hunt and eat other primates too 2Caltech biologists spy on the secret inner life of a cell 2Caltech biologists spy on the secret inner life of a cell 3Important new hair-loss gene discovered 2
(Date:12/11/2009)... Md., Dec. 11 EntreMed, Inc. (Nasdaq: ... $1.7 million in royalty revenue from sales of ... royalty revenue of $3.3 million. In addition, ... and projected revenue for fiscal 2009. The ... third quarter will be reflected in the fourth ...
(Date:12/11/2009)... 10, 2009 miRagen Therapeutics, Inc., a biopharmaceutical ... innovative microRNA-based therapeutics for cardiovascular and muscle disease, ... microRNA-206 (miR-206) plays a crucial role in the ... Gehrig,s disease) and in neuromuscular synaptic regeneration in ... 11 issue of the journal Science , ...
(Date:12/11/2009)... Boston College researchers have observed the "hot electron" effect ... successfully harvested the elusive charges using ultra-thin solar cells, ... the authors report in the current online edition of ... captured in solar cells, it generates free electrons in ... snare these charges, the electrons must reach the bottom ...
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer therapeutics company, ... the,US, the Tulane Cancer Center, New Orleans, ... clinical study of Alpharadin in men with,castration-resistant ... has metastasized to the skeleton. , ... SYMptomatic Prostate CAncer) study is a,double-blind, randomized, ...
Breaking Biology Technology:EntreMed Reports Receipt of Third Quarter Royalty Payment 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Elusive 'hot' electrons captured in ultra-thin solar cells 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4